Efficacy of botulinum toxin type A in idiopathic detrusor overactivity confirmed in large study March 24, 2011
Theravida's THVD-201 reduces symptoms of dry mouth in phase I trial in OAB, phase II study under way March 24, 2011
Personalized peptide vaccine shows promise in patients with resistant urothelial carcinoma March 24, 2011
Preliminary data from phase III trial support feasibility of rHuPH20-faciliated IGSC therapy March 24, 2011